Related Experiment Video
Updated: Jun 25, 2026

Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
Chemotherapy-related posterior reversible leukoencephalopathy syndrome
Archit Bhatt1, Muhammad U Farooq, Arshad Majid
1Department of Neurology and Ophthalmology, Michigan State University, East Lansing, MI 48823, USA. archit.bhatt@ht.msu.edu
Background:
A 45-year-old woman with small-cell lung cancer presented to a hospital emergency department in an acute confusional state, with blurred vision and mild headache. Following progressively increasing lethargy, she subsequently became unresponsive to tactile and verbal stimuli. She had recently been started on chemotherapy with carboplatin and gemcitabine.
Investigations:
Physical examination, imaging studies including brain MRI, noncontrast brain CT scans and magnetic resonance angiography, continuous EEG monitoring, and cerebrospinal fluid analysis.
Diagnosis:
Posterior reversible leukoencephalopathy syndrome (PRES) related to chemotherapy, and nonconvulsive status epilepticus related to PRES.
Management:
Withholding of chemotherapeutic agents, and antiseizure therapy for the status epilepticus.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Hepatic Encephalopathy
Antiprotozoal Agents
Cytotoxic Edema: Pathophysiology
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Encephalitis l: Introduction